NICE has backed Emgality (galcanezumab) as a once-monthly injection to prevent migraine attacks in people with episodic or chronic migraine who suffer at least four days with a migraine headache ...

There is more competition in play for Emgality from Lundbeck’s new intravenous ... in a clinic rather than by subcutaneous self-injection. Amgen reported $306 million from US sales of Aimovig ...

Doctors and scientists believe migraine is due to "the result of abnormal brain activity affecting nerve signals, chemicals ...

When giving gluteal injections, it is safest to use the upper outer quadrant. The choice of site for injection must be based on good clinical judgment, using the best evidence available and ...

The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin ...